STAR0602 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10 (month) in 2mo
ESTIMATED |
READOUT
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fu
Phase 1/2 · Advanced Solid Tumors, Genital Neoplasm, Female |
Marengo Therapeutics, Inc. | STAR0602 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|